S. Legrand et al. / Tetrahedron: Asymmetry 16 (2005) 635–640
639
bromobenzene (5.45 g, 34.71 mmol). The mixture was
stirred for 2 h at 0 ꢁC and at rt overnight. Then a satu-
tinuous gradient from cyclohexane to EtOAc. Recrystal-
lization of the crude crystals from mixture
cyclohexane/EtOAc gave 3d as a grey powder (0.38 g,
a
rated solution of NH Cl was added with some water and
4
20
the aqueous phase was extracted three times with
EtOAc. The combined organic phases were dried over
MgSO4 and evaporated to dryness. Recrystallization
of the crude solid from EtOH gave pure 3a as a white
33%). Mp = 261–264 ꢁC; ½aꢁ ¼ þ40:4 (c 1.04, CHCl ).
D
IR (KBr): 3284. H NMR (250 MHz, CDCl , 298 K):
3
1
3
3
3
d 7.31–7.28 (dd, J = 5.1, J = 1.1, 4H, H arom), 7.26–
3
3
7.24 (dd, J = 5.13, J = 1.1, 4H, H arom), 7.20–7.18
20
3
powder (1.32 g, 62%). Mp = 267–270 ꢁC; ½aꢁ ¼ ꢀ29:6
(dd,
7.07 (dd, J = 3.6, J = 1.2, 4H, H arom), 7.02–
J = 3.6,
J = 1.2, 4H,
H
arom), 7.09–
D
3
3
(
accordance to the work published by Tanaka et al.
c 0.98, CHCl ). The spectroscopic data found were in
3
1
3
3
6.99 (dd, J = 5.1, J = 3.6, 4H, H arom), 6.95–6.91
3
3
3
dd, J = 5.1, J = 3.6, 4H, H arom), 4.70 (br s, 4H,
(
4
4
1
· OH), 4.41 (s, 4H, 4 · CH), 1.59–1.48 (m, 8H,
4.4. (2R,3R,10R,11R)-Tetrakis[hydroxydi(1-naphthyl)-
methyl]-1,4,9,12-tetraoxadispiro[4.2.4.2]tetradecane 3b
13
· CH ); C NMR (66 MHz, CDCl , 298 K): 149.7,
2
3
45.5 (both C arom), 126.6 (CH arom), 126.55 (CH
arom), 126.52 (C arom), 125.8 (CH arom), 125.7 (CH
arom), 125.5 (CH arom), 109.8 (2 · OCO), 82.5
Same procedure as for compound 3a with 1-bromo-
naphthalene (15.9 g, 76.81 mmol) instead of bromobenz-
ene. The crude product was purified by MPLC using
cyclohexane/EtOAc (1:4) as the eluent. Recrystallization
from EtOH of the resulting crystals gave 3b as a white
(
4 · CH), 75.7 (4 · C(C H ) ), 33.4 (4 · CH );
6
5 2
2
+
HRMS calcd for C H O S Na (M+Na) 999.0387.
46 40
8 8
Found 999.0363. Anal. Calcd for C H O S : C,
46 40
8 8
20
56.53; H, 4.13; S, 26.25. Found: C, 56.80; H, 4.50; S,
25.80.
powder (5.44 g, 80%). Mp = 235–240 ꢁC; ½aꢁ ¼ ꢀ47:5
D
1
(
c 1.01, CHCl ). H NMR (500 MHz, DMSO-d ,
3 6
3
53 K): d 8.00–6.70 (m, 56H, H arom), 5.50–4.90 (2 br
s, 8H, 4 · CH and 4 · OH), 2.20–1.00 (m, 8H,
4.7. Dynamic NMR
1
3
4
1
1
1
· CH ); C NMR (125 MHz, DMSO-d , 353 K): d
2
6
1
45.0, 134.0, 133.9, 133.4, 132.1, 131.9, 131.0, 128.2,
27.7, 127.6, 127.1, 126.1, 124.7, 124.4, 124.2, 124.0,
23.8, 123.7, 123.2 (all C arom or CH arom, and
H NMR spectra were recorded at 500 MHz. The sol-
vents used were acetone-d6 (99.8%) and DMSO-d6
(99.8%).
OCO), 80.1, 71.1 (4 · CH and 4 · C(C H ) ), 31.4
6
5 2
+
(
4 · CH ); HRMS calcd for C H O Na (M+Na)
2
94 72
8
4.8. NMR titrations
1
C H O : C, 84.91; H, 5.46. Found: C, 84.63; H,
5
351.5125. Found 1351.5104. Anal. Calcd for
9
4
72
8
A solution of the TADDOL (5 mM) in CDCl3 was
titrated with consecutive addition of a solution, in the
same solvent, containing the host (37.5, 50 or
100 mM) and the TADDOL (5 mM). H NMR spectra
were recorded at 250 MHz at 298 K. CDCl (99.9%) was
.67.
1
4.5. (2R,3R,10R,11R)-Tetrakis[hydroxydi(2-naphthyl)-
methyl]-1,4,9,12-tetraoxadispiro[4.2.4.2]tetradecane 3c
3
used a solvent. Apparent dissociation constants were
calculated with non-linear line fitting to a one-site model
with the software package Prism (version 3.03, Graph-
Pad Software, USA). Each regression is based on not
less than seven data points and is presented with the
Same procedure as for compound 3a with 2-bromo-
naphthalene (15.9 g, 76.81 mmol) instead of bromobenz-
ene. The crude yellow crystals were recrystallized from
EtOH to give 3c as a white powder (5.1 g, 75%).
20
1
2
Mp = 190–196 ꢁC; ½aꢁ ¼ ꢀ42:6 (c 1.22, CHCl ).
H
standard error. The goodness of fit (R ) was 0.9182 or
better in all cases.
D
3
NMR (500 MHz, CDCl , 298 K): d 8.16 (s, 4H, H
3
arom), 7.89–7.86 (m, 12H, H arom), 7.75–7.68 (m,
1
(
2H, H arom), 7.58–7.50 (m, 16H, H arom), 7.41–7.37
m, 8H, H arom), 7.28–7.24 (dd, J = 1.7, J = 8.7, 4H,
4.9. Job plot
3
3
H arom), 4.86 (s, 4H, 4 · CH), 4.55 (br s, 4H,
Samples were prepared in CDCl (99.9%) containing dif-
3
1
3
4
· OH), 1.43–1.33 (m, 8H, 4 · CH );
C NMR
2
ferent molar fractions of the TADDOL 3c and a chiral
alcohol 4a or 4b from 0 to 1.0, with a constant total con-
centration of 8.3 mM. H NMR spectra were recorded
(
66 MHz, CDCl , 298 K): d 142.6, 140.2, 132.66,
3
1
32.60, 132.56, 128.6, 128.0, 127.5, 127.31, 127.28 (all
C arom), 127.0, 126.6, 126.1, 126.0, 125.7 (all CH arom),
09.4 (2 · OCO), 80.9 (4 · CH), 78.6, 77.2 (both
C(C H ) ), 33.7 (4 · CH ); HRMS calcd for
1
at 250 MHz at 298 K.
1
6
5 2
2
+
C H O Na (M+Na) 1351.5125. Found 1351.5129.
9
4
72
8
Acknowledgements
Anal. Calcd for C H O : C, 84.91; H, 5.46. Found:
9
4
72
8
C, 84.65; H, 5.62.
We thank P a¨ ivi Joensuu and Sari Ek (University of
Oulu, Finland), and Einar Nilsson (University of Lund,
Sweden) for HRMS measurements, Ari Koskela (Insti-
tute of Biotechnology, University of Helsinki, Finland)
and Ulla Jacobsson (Royal Institute of Technology,
Stockholm, Sweden) for assistance with the DNMR
experiments, and the University of Kalmar (Sweden)
for financial support.
4.6. (2R,3R,10R,11R)-Tetrakis[hydroxydi(2-thienyl)-
methyl]-1,4,9,12-tetraoxadispiro[4.2.4.2]tetradecane 3d
Same procedure as for compound 3a with 2-bromothio-
phene (2.83 g, 17.35 mmol) instead of bromobenzene.
The crude product was purified by MPLC using a con-